Michael Conlon

3.5k total citations
90 papers, 2.5k citations indexed

About

Michael Conlon is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Molecular Biology. According to data from OpenAlex, Michael Conlon has authored 90 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pediatrics, Perinatology and Child Health, 13 papers in Public Health, Environmental and Occupational Health and 12 papers in Molecular Biology. Recurrent topics in Michael Conlon's work include Prenatal Substance Exposure Effects (14 papers), Infant Development and Preterm Care (10 papers) and Maternal Mental Health During Pregnancy and Postpartum (7 papers). Michael Conlon is often cited by papers focused on Prenatal Substance Exposure Effects (14 papers), Infant Development and Preterm Care (10 papers) and Maternal Mental Health During Pregnancy and Postpartum (7 papers). Michael Conlon collaborates with scholars based in United States, Canada and United Kingdom. Michael Conlon's co-authors include A. I. Khuri, Marylou Behnke, Fonda Davis Eyler, Nanci Stewart Woods, Kathleen Wobie, W. H. Trethowan, Gene Cranston Anderson, Mary A. Bewick, Ronald G. Marks and Rhonda M. Cooper‐DeHoff and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Technometrics.

In The Last Decade

Michael Conlon

86 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Conlon United States 30 791 319 292 214 206 90 2.5k
Jen‐pei Liu Taiwan 28 244 0.3× 495 1.6× 160 0.5× 166 0.8× 260 1.3× 113 3.1k
John N. S. Matthews United Kingdom 35 279 0.4× 172 0.5× 481 1.6× 315 1.5× 401 1.9× 98 3.8k
Nigel Stallard United Kingdom 36 302 0.4× 1.2k 3.6× 286 1.0× 148 0.7× 376 1.8× 193 4.4k
Adrian Mander United Kingdom 31 232 0.3× 376 1.2× 962 3.3× 135 0.6× 301 1.5× 115 4.3k
Robert Temple United States 32 412 0.5× 107 0.3× 605 2.1× 584 2.7× 618 3.0× 78 6.9k
Donald J. Schuirmann United States 13 440 0.6× 474 1.5× 86 0.3× 104 0.5× 221 1.1× 21 2.6k
Fan Li United States 33 156 0.2× 163 0.5× 197 0.7× 160 0.7× 492 2.4× 269 4.3k
John Whitehead United Kingdom 33 229 0.3× 1.2k 3.7× 233 0.8× 329 1.5× 379 1.8× 147 4.8k
Martijn P. F. Berger Netherlands 28 350 0.4× 769 2.4× 373 1.3× 78 0.4× 72 0.3× 113 3.1k
Andrew P. Grieve United Kingdom 25 118 0.1× 384 1.2× 139 0.5× 328 1.5× 164 0.8× 81 2.7k

Countries citing papers authored by Michael Conlon

Since Specialization
Citations

This map shows the geographic impact of Michael Conlon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Conlon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Conlon more than expected).

Fields of papers citing papers by Michael Conlon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Conlon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Conlon. The network helps show where Michael Conlon may publish in the future.

Co-authorship network of co-authors of Michael Conlon

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Conlon. A scholar is included among the top collaborators of Michael Conlon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Conlon. Michael Conlon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Handberg, Eileen, C. Noel Bairey Merz, Rhonda M. Cooper‐DeHoff, et al.. (2021). Rationale and design of the Women's Ischemia Trial to Reduce Events in Nonobstructive CAD (WARRIOR) trial. American Heart Journal. 237. 90–103. 68 indexed citations
2.
Miles, Kevin, et al.. (2014). Public-private partnerships in the response to HIV: experience from the resource industry in Papua New Guinea. Rural and Remote Health. 14(3). 2868–2868. 6 indexed citations
3.
Migliorati, César A., et al.. (2013). Assessing the association between bisphosphonate exposure and delayed mucosal healing after tooth extraction. The Journal of the American Dental Association. 144(4). 406–414. 37 indexed citations
4.
Bakker, Debra, Michael Conlon, Margaret I. Fitch, et al.. (2012). Canadian Oncology Nurse Work Environments: Part II. Nursing leadership. 25(1). 68–69. 9 indexed citations
5.
Nelson, David R., et al.. (2011). University of Florida Clinical and Translational Science Institute: Transformation and Translation in Personalized Medicine. Clinical and Translational Science. 4(6). 400–402. 8 indexed citations
6.
7.
Bewick, Mary A., Robert M. Lafrenie, & Michael Conlon. (2010). Nucleotide excision repair polymorphisms and survival outcome for patients with metastatic breast cancer. Journal of Cancer Research and Clinical Oncology. 137(3). 543–550. 16 indexed citations
8.
Conlon, Michael, Kenneth C. Johnson, Mary A. Bewick, Robert M. Lafrenie, & Allan Donner. (2010). Smoking (active and passive), N-acetyltransferase 2, and risk of breast cancer. Cancer Epidemiology. 34(2). 142–149. 30 indexed citations
9.
Marks, Ronald G., et al.. (2009). Enhancing clinical trials on the internet: Lessons from INVEST. Clinical Cardiology. 24(S5). V–17. 16 indexed citations
10.
Bewick, Mary A., Michael Conlon, & Robert M. Lafrenie. (2007). Polymorphisms in manganese superoxide dismutase, myeloperoxidase and glutathione-S-transferase and survival after treatment for metastatic breast cancer. Breast Cancer Research and Treatment. 111(1). 93–101. 33 indexed citations
11.
Bewick, Mary A., et al.. (2001). Soluble Fas (CD95) Is a Prognostic Factor in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation. Journal of Hematotherapy & Stem Cell Research. 10(6). 759–768. 24 indexed citations
12.
13.
Marks, Ronald G., Michael Conlon, & Stephen J. Ruberg. (2001). Paradigm shifts in clinical trials enabled by information technology. Statistics in Medicine. 20(17-18). 2683–2696. 40 indexed citations
14.
Eyler, Fonda Davis, Marylou Behnke, Michael Conlon, Nanci Stewart Woods, & Kathleen Wobie. (1998). Birth Outcome From a Prospective, Matched Study of Prenatal Crack/Cocaine Use: I. Interactive and Dose Effects on Health and Growth. PEDIATRICS. 101(2). 229–236. 88 indexed citations
15.
Thomas, Ronald G. & Michael Conlon. (1992). Sample size determination based on fisher's exact test for use in 2 × 2 comparative trials with low event rates. Controlled Clinical Trials. 13(2). 134–147. 23 indexed citations
16.
Stechmiller, Joyce, et al.. (1991). Selected characteristics of nurses and physicians who have living wills. Death Studies. 15(2). 119–130. 1 indexed citations
17.
Abrams, R.M., et al.. (1990). Local cerebral blood flow is increased in rapid-eye-movement sleep in fetal sheep. American Journal of Obstetrics and Gynecology. 162(1). 278–281. 9 indexed citations
18.
Williams, Phoebe, et al.. (1988). Anxiety levels of rooming-in and non-rooming-in parents of young hospitalized children.. PubMed. 17(2). 79–99. 9 indexed citations
19.
Khuri, A. I. & Michael Conlon. (1981). Simultaneous Optimization of Multiple Responses Represented by Polynomial Regression Functions. Technometrics. 23(4). 363–375. 304 indexed citations
20.
Conlon, Michael. (1963). Addiction to Chlorodyne. BMJ. 2(5366). 1177–1178. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jen‐pei Liu Breakdown of academic impact, for papers by John N. S. Matthews Breakdown of academic impact, for papers by Nigel Stallard Breakdown of academic impact, for papers by Adrian Mander Breakdown of academic impact, for papers by Robert Temple Breakdown of academic impact, for papers by Donald J. Schuirmann Breakdown of academic impact, for papers by Fan Li Breakdown of academic impact, for papers by John Whitehead Breakdown of academic impact, for papers by Martijn P. F. Berger Breakdown of academic impact, for papers by Andrew P. Grieve
Rankless by CCL
2026